Peer2Peer: The Podcast

The world’s first spiral IOL has received FDA approval!

Our new host, Dr. Blake Williamson, sits down with US IDE trial investigators Dr. Eric Donnenfeld and Dr. Deb Ristvedt to review the initial US clinical outcomes and real-world surgeon feedback for the Galaxy intraocular lens (IOL).

Learn how this AI-designed, non-diffractive spiral optic provides continuous, glasses-free vision at all distances with minimal halo and glare - and discover where it can fit into your clinical practice.

Learn more at Galaxy - Rayner : USA

In this episode of Peer2Peer The Podcast, recorded live at AUSCRS, host Dr. Ben LaHood is joined by leading ophthalmic surgeons Dr. Dylan Joseph, Dr. Başak Bostancı and Mr. Kieren Darcy to discuss their clinical experience with the RayOne Galaxy spiral IOL.

The group explores visual outcomes and night-vision performance, sharing how the lens handles both standard patients and those with high visual demands, including sea rescue workers and police officers.

The discussion also tackles more complex surgical scenarios, offering practical guidance on post-LASIK cases and fine-tuning refractive adjustments. Whether you are looking to understand routine patient selection or navigate challenging cases, the panel provides direct, actionable takeaways from real-world practice.

Visit rayner.com/Galaxy to learn more!

Within an increasingly crowded Increased Range of Focus (IROF) lens market, how does RayOne EMV compare to traditional EDOF options?

In this episode of Peer2Peer: The Podcast, Dr. Ben LaHood is joined by Prof. Graham Barrett alongside US ophthalmic surgeons Dr. Karolinne Rocha and Dr. Blake Williamson for an honest, clinical discussion on RayOne EMV and IROF technology. Grounded in real-world surgical experience and clinical data rather than theory, they explore how different optical profiles stack up and how to optimise patient selection in modern refractive practice.

Non-Diffractive Optics: How RayOne EMV utilises controlled positive spherical aberration to extend depth of focus without light-splitting or halos.

EMV vs. EDOF Comparisons: Head-to-head optical and clinical comparisons with PureSee and others, and whether "EDOF" is still a useful catch-all term.

Patient Selection & Counselling: Identifying ideal candidates, managing expectations, and effectively counselling patients who request specific lenses by name.

Tune in for practical advice and honest comparisons from the experts!

Explore the clinical data behind RayOne EMV 👉 RayOne EMV Premium IOL | Rayner Global

Can emerging technology genuinely solve daily clinic friction and give ophthalmologists their time back, or is it simply adding to the noise?

In this episode, host Dr. Ben LaHood is joined by ophthalmic innovators Dr. Eric Rosenberg and Dr. Stanley Windsor for an honest, clinical discussion on emerging digital health tools. Grounded in real-world practice, they explore how technology is beginning to reshape the patient journey, clinic workflows and the surgical experience.

Request an eyejourney demo: To see how automated patient education can optimise your clinical workflow, book a demo at 👉 eyejourney.ai

Tune in to this AI-powered Deep Dive to unpick the question that changes how we think about long-term lens clarity! 

Does IOL material really matter for keeping the capsule clear? In this high-energy clinical breakdown, we dissect a landmark 12-month randomised controlled trial (RCT) by Naderi et al. from the Journal of Cataract & Refractive Surgery. Two identical lens designs by Rayner are pitted directly against each other - the hydrophilic RayOne 600C versus the hydrophobic RayOne 800C - to isolate material performance like never before. 

In just a few minutes, you’ll discover: 

Please note: Ahead of open access to this clinical paper becoming available, subscribers of JCRS can access the full study here: Journal of Cataract & Refractive Surgery

This podcast was created with the assistance of artificial intelligence. While every effort has been made to ensure accuracy, listeners are encouraged to refer to the original publications for complete details. 

Listen to our AI-powered Deep Dive into five key peer-reviewed publications analysing the clinical performance of RayOne EMV.

This enhanced monofocal lens is redefining the standard for "forgiving" optics, using a non-diffractive design to bridge the gap between distance and intermediate vision. We cut through the data and deliver the key findings from five distinct studies in a fast, clinical discussion you can't afford to miss.

In this 12-minute breakdown, you will hear:

Monovision vs. Emmetropia: The data-backed argument for a modest monovision strategy to double your patient's depth of focus.

The "Forgiveness" Factor: How the lens maintains functional vision even with a refractive target offset, offering a massive 2.5 D landing zone.

Night Driving & Quality of Life: Why 95% of patients rated their night vision as good as or better than before surgery, with zero spontaneous reports of dysphotopsia (halos/glare).

Read more in our clinical paper summary: RAYP26142_RayOne-EMV-Peer-reviewed-publication-sheet-02-26-v3.pdf

This podcast was created with the assistance of artificial intelligence. While every effort has been made to ensure accuracy, listeners are encouraged to refer to the original publications for complete details.

In this episode of Peer2Peer: The Podcast, host Dr Ben LaHood is joined by Dr Dylan Joseph, Dr Johann Kruger and Dr Uday Devgan for a roundtable conversation recorded live at SASCRS 2026.

Together, they explore “The Visible Ophthalmologist - Building reputation in the digital landscape" and why building a professional presence in the digital landscape is becoming an essential part of modern ophthalmology.

From social media and podcasts to peer-to-peer education and patient engagement, the panel share their journey - from being hesitant to post online to becoming recognised voices within the global ophthalmology community.

In this episode, we cover:

🎧 Tune in to hear practical advice, honest reflections and lessons learned from surgeons who have successfully navigated the evolving digital landscape in ophthalmology.

Growth in ophthalmology no longer starts in the operating room - it starts with the patient experience.

In this episode of Peer2Peer: The Podcast, host Dr Ben LaHood is joined by Dr Erik Mertens and Amanda Cardwell Carones to explore how deliberately designing the patient journey can transform patient satisfaction, strengthen trust and build a thriving, future-ready practice.

In this episode, we cover:

This episode is essential listening for ophthalmologists, cataract surgeons, clinic owners and healthcare leaders looking to connect clinical excellence with business success - without losing sight of what matters most: the patient.

Hear our AI-powered Deep Dive into the first peer-reviewed paper on the RayOne Galaxy spiral IOL.

This revolutionary non-diffractive lens was designed with AI, and the clinical results are speaking for themselves. We cut through the jargon and deliver the key findings in a fast, 15-minute discussion you can't afford to miss. In this 15-minute breakdown, you will learn:

- Why patients rate halo and glare levels with Galaxy as 'very low'.

- The sweet spot of functional vision: a smooth defocus curve spanning from +1.00 D to –2.80 D.

- The role of AI-assisted design in perfecting the optic before it ever entered an eye.

- The core data: Excellent monocular and binocular visual acuity across all tested distances.

Read the full paper for more information: https://journals.healio.com/doi/epdf/10.3928/1081597X-20250829-01

This podcast was created with the assistance of artificial intelligence. While every effort has been made to ensure accuracy, listeners are encouraged to refer to the original publication for complete details.

In this episode of Peer2Peer by Rayner, host Dr Ben LaHood (Australia) is joined by Mr Allon Barsam (UK) and Dr Deb Ristvedt (USA) to discuss the exciting news that RayOne EMV Toric has received FDA approval.

Together, they explore:

The clinical pathway and IDE study behind FDA approval.

How RayOne EMV Toric’s global success shaped its journey to the US market.

Surgical pearls and insights from experienced international users.

Why this milestone represents a new era for astigmatism correction in cataract surgery.

With RayOne EMV and EMV Toric lenses implanted worldwide in 75+ countries, this episode highlights how proven performance and surgeon trust have paved the way for US approval.